rs77245812

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002381.5(MATN3):​c.908C>T​(p.Thr303Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0158 in 1,613,922 control chromosomes in the GnomAD database, including 321 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 22 hom., cov: 33)
Exomes 𝑓: 0.016 ( 299 hom. )

Consequence

MATN3
NM_002381.5 missense

Scores

10
3
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:6O:1

Conservation

PhyloP100: 9.32
Variant links:
Genes affected
MATN3 (HGNC:6909): (matrilin 3) This gene encodes a member of von Willebrand factor A domain containing protein family. This family of proteins is thought to be involved in the formation of filamentous networks in the extracellular matrices of various tissues. This protein contains two von Willebrand factor A domains; it is present in the cartilage extracellular matrix and has a role in the development and homeostasis of cartilage and bone. Mutations in this gene result in multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
WDR35-DT (HGNC:55818): (WDR35 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.018800974).
BP6
Variant 2-20003169-G-A is Benign according to our data. Variant chr2-20003169-G-A is described in ClinVar as [Benign]. Clinvar id is 7542.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-20003169-G-A is described in Lovd as [Pathogenic]. Variant chr2-20003169-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0121 (1837/152310) while in subpopulation SAS AF= 0.0381 (184/4824). AF 95% confidence interval is 0.0336. There are 22 homozygotes in gnomad4. There are 872 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 22 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MATN3NM_002381.5 linkuse as main transcriptc.908C>T p.Thr303Met missense_variant 3/8 ENST00000407540.8 NP_002372.1
WDR35-DTNR_110235.1 linkuse as main transcriptn.364-851G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MATN3ENST00000407540.8 linkuse as main transcriptc.908C>T p.Thr303Met missense_variant 3/81 NM_002381.5 ENSP00000383894 P1O15232-1
MATN3ENST00000421259.2 linkuse as main transcriptc.791-1089C>T intron_variant 1 ENSP00000398753 O15232-2
WDR35-DTENST00000416575.2 linkuse as main transcriptn.357-851G>A intron_variant, non_coding_transcript_variant 2
WDR35-DTENST00000658200.1 linkuse as main transcriptn.2226G>A non_coding_transcript_exon_variant 3/3

Frequencies

GnomAD3 genomes
AF:
0.0121
AC:
1840
AN:
152192
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00297
Gnomad AMI
AF:
0.111
Gnomad AMR
AF:
0.00955
Gnomad ASJ
AF:
0.0211
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0383
Gnomad FIN
AF:
0.00339
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0166
Gnomad OTH
AF:
0.0158
GnomAD3 exomes
AF:
0.0151
AC:
3771
AN:
249204
Hom.:
62
AF XY:
0.0171
AC XY:
2312
AN XY:
135194
show subpopulations
Gnomad AFR exome
AF:
0.00252
Gnomad AMR exome
AF:
0.00519
Gnomad ASJ exome
AF:
0.0199
Gnomad EAS exome
AF:
0.000167
Gnomad SAS exome
AF:
0.0444
Gnomad FIN exome
AF:
0.00418
Gnomad NFE exome
AF:
0.0160
Gnomad OTH exome
AF:
0.0149
GnomAD4 exome
AF:
0.0162
AC:
23730
AN:
1461612
Hom.:
299
Cov.:
31
AF XY:
0.0171
AC XY:
12423
AN XY:
727092
show subpopulations
Gnomad4 AFR exome
AF:
0.00254
Gnomad4 AMR exome
AF:
0.00593
Gnomad4 ASJ exome
AF:
0.0207
Gnomad4 EAS exome
AF:
0.000101
Gnomad4 SAS exome
AF:
0.0443
Gnomad4 FIN exome
AF:
0.00496
Gnomad4 NFE exome
AF:
0.0159
Gnomad4 OTH exome
AF:
0.0153
GnomAD4 genome
AF:
0.0121
AC:
1837
AN:
152310
Hom.:
22
Cov.:
33
AF XY:
0.0117
AC XY:
872
AN XY:
74470
show subpopulations
Gnomad4 AFR
AF:
0.00296
Gnomad4 AMR
AF:
0.00954
Gnomad4 ASJ
AF:
0.0211
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0381
Gnomad4 FIN
AF:
0.00339
Gnomad4 NFE
AF:
0.0166
Gnomad4 OTH
AF:
0.0156
Alfa
AF:
0.0153
Hom.:
30
Bravo
AF:
0.0109
TwinsUK
AF:
0.0151
AC:
56
ALSPAC
AF:
0.0150
AC:
58
ESP6500AA
AF:
0.00494
AC:
20
ESP6500EA
AF:
0.0146
AC:
122
ExAC
AF:
0.0161
AC:
1950
Asia WGS
AF:
0.0160
AC:
54
AN:
3478
EpiCase
AF:
0.0173
EpiControl
AF:
0.0178

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Multiple epiphyseal dysplasia type 5 Pathogenic:1Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaMar 06, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 2004- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 22, 2018- -
Connective tissue disorder Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJan 31, 2022- -
MATN3-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 28, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Osteoarthritis susceptibility 2 Other:1
risk factor, no assertion criteria providedliterature onlyOMIMJun 01, 2003- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.0054
T
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.78
D
Eigen
Pathogenic
0.91
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.019
T
MetaSVM
Uncertain
0.68
D
MutationAssessor
Pathogenic
3.3
M
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-5.3
D
REVEL
Pathogenic
0.66
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.32
MPC
0.76
ClinPred
0.046
T
GERP RS
5.5
Varity_R
0.78
gMVP
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77245812; hg19: chr2-20202930; COSMIC: COSV99067488; API